Works matching IS 1021335X AND DT 2025 AND VI 53 AND IP 2
Results: 15
Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K/AKT/mTOR signaling pathway.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2025.8864
- By:
- Publication type:
- Article
[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2025.8863
- By:
- Publication type:
- Article
Hypoxia studies in non‑small cell lung cancer: Pathogenesis and clinical implications (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8862
- By:
- Publication type:
- Article
[Retracted] Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8856
- By:
- Publication type:
- Article
Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8855
- By:
- Publication type:
- Article
[Retracted] Inhibition of 5‑lipoxygenase triggers apoptosis in pancreatic cancer cells.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8853
- By:
- Publication type:
- Article
Epigenetic silencing of JAM3 promotes laryngeal squamous cell carcinoma development by inhibiting the Hippo pathway.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8861
- By:
- Publication type:
- Article
SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8857
- By:
- Publication type:
- Article
Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8854
- By:
- Publication type:
- Article
Impact of miRNAs involved in the STAT3 signaling pathway on esophageal cancer (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8860
- By:
- Publication type:
- Article
Bcl‑xL‑specific BH3 mimetic A‑1331852 suppresses proliferation of fluorouracil‑resistant colorectal cancer cells by inducing apoptosis.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8859
- By:
- Publication type:
- Article
Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8858
- By:
- Publication type:
- Article
Biological implications of decoding the extracellular matrix of vulva cancer.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8852
- By:
- Publication type:
- Article
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review).
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8851
- By:
- Publication type:
- Article
[Retracted] Hypoxia‑induced overexpression of DEC1 is regulated by HIF‑1α in hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2025, v. 53, n. 2, p. N.PAG, doi. 10.3892/or.2024.8850
- By:
- Publication type:
- Article